BofA/Merrill Lynch Upgrades Edwards Lifesciences (EW) to Buy
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $86.89 +1.18%
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
29 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $108.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- ITG launches IPO roadshow, seeks Nasdaq listing at up to $22 per share
- ITG targets $2.67 billion valuation in U.S. IPO
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
